Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa

European Journal of Pharmacology

Volumn 318, Issue 2-3, 1996, Pages 469-475

  Sheu, Joen Rong ^a   Hung, Wei Chun ^a   Lee, Yen Mei ^b   Yen, Mao Hsiung ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Alkaloid; cAMP; cGMP; Phosphoinositide; Platelet, human; Rutaecarpine; Thromboxane A2

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ALKALOID; ARACHIDONIC ACID; COLLAGEN; CYCLIC AMP; CYCLIC GMP; GUANYLATE CYCLASE; INOSITOL PHOSPHATE; METHYLENE BLUE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RUTAECARPINE; THROMBIN; THROMBOXANE B2;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ALKALOIDS; BLOOD PLATELETS; CYCLIC AMP; CYCLIC GMP; HUMANS; NITRIC OXIDE; PHOSPHATIDYLINOSITOLS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOXANE B2;

EID: 0030607693     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00789-3     Document Type: Article

References (33)

1. 32P) phosphate, Biochem. J. 162, 61.
2. Bell, R.L., D.A. Kennerly, N. Stanford and P.W. Majerus, 1979, Diglyceride lipase: a pathway for arachidonic acid release from human platelets, Proc. Natl. Acad. Sci. USA 76, 3238.
3. Berridge, M.J., 1983, Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol, Biochem. J. 212, 249.
4. Born, G.V.R. and M.J. Cross, 1963, The aggregation of blood platelets, J. Physiol. 168, 178.
5. Broekman, M.J., J.W. Ward and A.J. Marcus, 1980, Phospholipid metabolism in stimulated human platelets. Changes in phosphatidyl inositol, phosphatic acid and lysophospholipids, J. Clin. Invest. 66, 275.
6. Chang, H.M, and P.P.H. But, 1987, Pharmacology and Applications of Chinese Materials Medica, Vol. 1 (World Scientific Publishing, Singapore) p. 605.
7. Chen, C.F., S.M. Chen, M.T. Lin and S.Y. Chow, 1981, In vivo and in vitro studies on the mechanism of the cardiovascular effect of Wu-Chu-Yu (Evodiae fructus), Am. J. Chinese Med. 1, 39.
8. Chiou, W.F., C.J. Chou, A.Y.C. Shum and C.F. Chen, 1992, The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action, Eur. J. Pharmacol. 215, 277.
9. Chiou, W.F., C.J. Chou, J.F. Liao, A.Y.C. Sham and C.F. Chen, 1994, The mechanism of the vasodilator effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, Eur. J. Pharmacol. 257, 59.
10. Chow, S.Y., S.M. Chen and C.M. Yang, 1976, Pharmacological studies on Chinese herbs. 3. Analgesic effect of 27 Chinese drugs in mice, J. Formos. Med. Assoc. 75, 349.
11. Hamberg, M., J. Suensson and J. Samuelsson, 1975, Thromboxanes: a new group of biological active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad. Sci. USA 72, 2994.
12. 2 production, Biochem. Pharmacol. 31, 1158.
13. Karniguian, A., Y.J. Legrand and J.P. Caem, 1982, Prostaglandin: specific inhibition of platelet adhesion to collagen and relationship with cAMP level, Prostaglandins 23, 437.
14. Kirk, C.J., J.A. Creba, C.P. Downes and R.H. Michell, 1981, Hormonestimulated metabolism of inositol lipids and its relationship to hepatic receptor function, Biochem. Soc. Trans. 9, 377.
15. Kornecki, E., S. Niewiarowski, T.A. Morinelli and M. Kloczewiak, 1981, Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets, J. Biol. Chem. 256, 5696.
16. Kornecki, E., Y.H. Ehrlich, D.D. De Mars and R.H. Lenox, 1986, Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase, J. Clin. Invest. 77, 750.
17. Li, S.C., 1596, Pen-Tsao Kang Mu (republished by National Research Institute of Chinese Medicine, 1976, Taipei) Chapter 32, p. 1064.
18. Liao, J.F., C.F. Chen and S.Y. Chow, 1981, Pharmacological studies of Chinese herbs. 9. Pharmacological effects of Evodiae fructus, J. Formos. Med. Assoc. 79, 30.
19. 2+ flux in human platelet activation, Adv. Exp. Med. Biol. 192, 127.
20. Mckean, M.L., J.B. Smith and W.J. Silver, 1981, Formation of lysophosphatidylcholine in human platelets in response to thrombin, J. Biol. Chem. 256, 1522.
21. Molina, C., J.W. Andresen, R.M. Rapaport, S.A. Waldman and F. Murad, 1987, Effects of in vivo nitroglycerin therapy on endothelium-dependent and -independent relaxation and cyclic GMP accumulation in rat aorta, J. Cardiovasc. Pharmacol. 10, 371.
22. Mustard, J.F., D.W. Perry, N.G. Ardlie and M.A. Packham, 1972, Preparation of suspensions of washed platelets from humans, Br. J. Pharmacol. 22, 193.
23. 1-adrenoceptors in rat kidney mediates increased inositoi phospholipid hydrolysis, Br. J. Pharmacol. 91, 367.
24. Niewiarowski, S., A.Z. Budzynski, T.A. Morinelli, T.M. Brudzynski and G.L. Stewart, 1981, Exposure of fibrinogen receptor on human platelets by proteolytic enzyme, J. Biol. Chem. 256, 917.
25. Radomski, M.W., P.M.J. Palmer and S. Moncada, 1990a, An L-arginine/nitric oxide pathway present in human platelets regulates aggregation, Proc. Natl. Acad. Sci. USA 87, 5193.
26. Radomski, M.W., R.M.J. Palmer and S. Moncada, 1990b, Characterization of the L-arginine : nitric oxide pathway in human platelets, Br. J. Pharmacol. 101, 325.
27. Shoji, N., A. Umeyama, T. Takemoto, A. Kajiwara and Y. Ohizumi, 1986, Isolation of evodiamine, a powerful cadiotonic principle, from Euodia rutaecarpa Bentham (Rutaceae), J. Pharm. Sci. 75, 612.
28. Thadani, U., 1992, Role of nitrates in angina pectoris, Am. J. Cardiol. 70, 43B.
29. Yamahara, J., T. Yamada, T. Kitani, Y. Naiton and H. Fujimura, 1989, Antianoxic action of evodiamine and alkaloid in Euodia rutaecarpa fruit, J. Ethnopharmacol. 27, 185.
30. Yang, H.Y., S.Y. Li and C.F. Chen, 1988, Hypotensive effects of dehydroevodiamine, a quinazolinocarboline alkaloid isolated from Euodiae rutaecarpa, Asia Pac. J. Pharmacol. 3, 191.
31. Yang, M.C.M., S.L. Wu, J.S. Kao and C.F. Chen, 1990, The hypotensive and negative chronotropic effect of dehydroevodiamine, Eur. J. Pharmacol. 182, 537.
32. 2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase, Biochem. Biophys. Res. Commun. 120, 579.
33. Zhou, Q., G.R. Hellermann and L.P. Solomonson, 1995, Nitric oxide release from resting human platelets, Thromb. Res. 77, 87.